Sudden hearing loss associated with methylphenidate therapy
Autor: | Engin Dursun, Ugur Karapinar, Bilal Cetin, Nergis Salman, Omer Saglam, Murat Sahan |
---|---|
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
Hearing loss Physical examination Audiology Hearing Ototoxicity otorhinolaryngologic diseases medicine Humans Attention deficit hyperactivity disorder Medical history Child Glucocorticoids Hyperbaric Oxygenation medicine.diagnostic_test Methylphenidate business.industry General Medicine Audiogram Hearing Loss Sudden medicine.disease Otorhinolaryngology Prednisone Central Nervous System Stimulants Female medicine.symptom business Tinnitus medicine.drug |
Zdroj: | European Archives of Oto-Rhino-Laryngology. 271:199-201 |
ISSN: | 1434-4726 0937-4477 |
DOI: | 10.1007/s00405-013-2763-y |
Popis: | An 8-year-old child diagnosed with attention deficit/hyperactivity disorder presented to our Department of Otolaryngology 4 days after suffering hearing loss, loss of balance, tinnitus, and fullness sensation of the left ear. Her symptoms occured with the first dose of methylphenidate. The medical history and physical examination revealed no other diseases associated with sudden hearing loss. The audiogram revealed a total hearing loss on the left ear. Stapedial reflexes, distortion product and transient-evoked otoacoustic emissions were absent in left ear. The absence of clinical, laboratory and radiological evidence of a possible cause for complaints, an association between methylphenidate and sudden hearing loss was suggested. The patient received a standard course of oral corticosteroid and hyperbaric oxygen therapy. Weekly otological and audiological examinations were performed. Conservative and medical treatments offered no relief from hearing loss. Sudden hearing loss is a serious and irreversible adverse effect of methylphenidate. Therefore, the risk of hearing loss should be taken into consideration when initiating methylphenidate therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |